X-linked reticulate pigmentary disorder

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics

X-linked reticulate pigmentary disorder
Synonyms	X-linked reticulate pigmentary disorder with systemic manifestations
Pronounce	N/A
Specialty	N/A
Symptoms	Skin pigmentation, Recurrent infections, Pulmonary fibrosis, Renal failure
Complications	N/A
Onset	Infancy
Duration	Chronic
Types	N/A
Causes	Genetic mutation in the POLA1 gene
Risks	Family history
Diagnosis	Genetic testing, Clinical evaluation
Differential diagnosis	Other pigmentary disorders, Immunodeficiency disorders
Prevention	N/A
Treatment	Symptomatic treatment, Supportive care
Medication	N/A
Prognosis	Variable, depends on severity of systemic involvement
Frequency	Rare disease
Deaths	N/A

File:01.bolnye-XLPDR.png

X-linked reticulate pigmentary disorder (XLRPD) is a rare genetic disorder characterized by distinctive skin pigmentation, recurrent infections, and other systemic abnormalities. It is inherited in an X-linked recessive manner, meaning the gene responsible for the disorder is located on the X chromosome.

Clinical Features

Individuals with XLRPD typically present with a reticulate (net-like) pattern of hyperpigmentation and hypopigmentation on the skin. This pigmentation often appears in infancy or early childhood and can affect various parts of the body, including the trunk, extremities, and face. Other common features include:

• Recurrent bacterial infections
• Chronic diarrhea
• Failure to thrive
• Hepatosplenomegaly (enlarged liver and spleen)
• Lymphadenopathy (swollen lymph nodes)
• Immune system abnormalities

Genetics

XLRPD is caused by mutations in the POLA1 gene, which encodes the catalytic subunit of DNA polymerase alpha. This enzyme is essential for DNA replication and cell division. The disorder follows an X-linked recessive inheritance pattern, meaning that males are typically more severely affected than females. Females who carry one mutated copy of the gene may exhibit mild symptoms or be asymptomatic carriers.

Diagnosis

The diagnosis of XLRPD is based on clinical findings, family history, and genetic testing. Molecular genetic testing can identify mutations in the POLA1 gene, confirming the diagnosis. Additional tests may include:

• Skin biopsy to examine the pigmentation pattern
• Blood tests to assess immune function
• Imaging studies to evaluate organ involvement

Management

There is no cure for XLRPD, and treatment is primarily supportive. Management strategies may include:

• Antibiotics for recurrent infections
• Nutritional support for growth and development
• Regular monitoring of organ function
• Immunoglobulin replacement therapy for immune deficiencies

Prognosis

The prognosis for individuals with XLRPD varies depending on the severity of the symptoms and the effectiveness of the management strategies. Early diagnosis and appropriate medical care can improve the quality of life and outcomes for affected individuals.

See Also

• Genetic disorders
• X-linked recessive inheritance
• Immune system disorders

External Links

-

This article is a stub related to genetics. You can help WikiMD by expanding it!

   This article is a medical stub. You can help WikiMD by expanding it!